Alexandria Real Estate Equities, Inc., Landlord of Choice to the Life Science IndustryÂ®, is the largest owner and pre-eminent first-in-class real estate investment trust focused principally on science-driven cluster formation. Alexandria is the leading provider of real estate to the life science industry, and has an outstanding 11 year track record as a NYSE listed company with an approximate $5.2 billion total market capitalization (as of December 31, 2008).
|Theraclone Sciences||3/13||Series B||$8M||8|
|Oncofactor Corporation||8/11||Series A||$2.1M||6|
|Acylin Therapeutics||1/11||Series A||$4.4M||4|
|Theraclone Sciences||3/10||Venture Round||$1.5M||6|
|Cambrios Technologies||11/09||Series D||$14.5M||14|
|Cerulean Pharma||1/08||Series B||$8.1M||5|